GLP-1 Utilization in New York City Is Not Correlated with Clinical Indication September 10, 2023 Key Takeaways GLP-1s have the potential to revolutionize clinical treatment of obesity and diabetes, but current utilization patterns of GLP-1s are not correlated with clinical disease, primarily because of off-label use
Irawati N, Wardani RS, Poerbonegoro NL, Rahmawati I
Eapen, MD, says, Many patients take medication for at least 6-12 months, but some may need longer-term management
Lower inflammation (a driver of atherosclerosis) Atherosclerosis (plaque buildup) is not just a plumbing issueits an inflammatory process
The I could eat the entire fridge luteal phase has softened into something much more manageable and normal
Tier 1 library (DnsID library) contains accurate mass, MS/MS, and retention time information